The question whether coffee has a negative or a positive impact on human health has been the topic of much heated debate for years. Nevertheless, recent studies have not only failed to confi rm earlier concerns, but in fact suggested a positive effect of coffee intake. Latest studies revealed that people who drink at least 3 cups of coffee per day are at a lower risk for type 2 diabetes, as well as liver and colon cancer. The reports on a possible correlation between coffee drinking and heart diseases have also generated optimistic results. No adverse associations between coffee consumption and coronary heart disease, stroke, and hypertension have been found. What is more, some authors demonstrated that coffee drinking may prevent cardiovascular diseases. Composition of coffee is determined by the strength of the brew and brewing methods. Unfi ltered coffee is rich in cholesterol--raising diterpenes, therefore patients with dyslipidemia should be advised to drink fi ltered rather than non-fi ltered coffee. On the other hand coffee contains polyphenols which act as antioxidants, and these compounds are probably responsible for the suggested benefi cial effect of coffee on health. This article summarizes the current literature reports on this controversial topic.
INTRODUCTION
Coffee consumption is associated with diverse health effects. Owing to its widespread popularity, the effects of coffee on health, including cardiovascular diseases, cancer, osteoporosis, diabetes and neurological diseases, have been extensively studied for many years. Two and three decades ago consumption of coffee was predominantly reported to constitute a risk factor and the impact of coffee on health remains controversial until today. However, recent research has suggested that coffee consumption has no adverse effects and may even help prevent several chronic diseases, including type 2 diabetes mellitus, liver cancer and Parkinson's disease [Akash et Sudano et al., 2005] . For example, data from Finland indicates lower mortality and morbidity rates among coffee drinkers as compared to non-drinkers with regard to many common chronic diseases [Tuomilehto, 2013] .
COFFEE AND CARDIOVASCULAR HEALTH
Longitudinal studies have generated confl icting data about the effects of coffee consumption on the cardiovascular system. Meta-analysis of case-control studies conducted in the 90s revealed that people who consumed 5 cups of coffee per day were at a 60% higher risk of coronary heart disease than their non-drinking peers [Kawachi et al., 1994] . Recent publications have been more optimistic and most of them suggest that coffee consumption not only does not constitute a cardiovascular risk factor, and may in fact be benefi cial to health [Akash et al., 2014; Numerous studies conducted by Lopez Garcia et al. have provided strong evidence against the hypothesis that coffee consumption increases the risk of cardiovascular diseases [Lopez-Garcia et al., 2006 . They found that long-term coffee consumption (even 6 cups/day) does not increase the risk of coronary heart disease, stroke, and premature death due to cardiovascular diseases. Woodward and Tunstall-Pedoe [1999] revealed that an intake of 3-4 cups of coffee per day is associated with a lower risk of cardiovascular diseases among men but not among women. Three meta-analyses of prospective cohort trials concerning this matter have recently been published. A meta-analysis by Wu et al. [2009] suggested that moderate coffee consumption (>1-2 cups/day) may decrease a long-term risk of coronary heart disease by 13%. Ding et al. [2014] concluded that moderate coffee consumption was inversely associated with CVD risk, with the lowest risk at 3-5 cups of coffee per day, and that heavy coffee consumption was not associated with elevated CVD risk. In turn, Mostofsky et al. [2012] reported an inverse association between moderate coffee consumption and risk of heart failure, with the strongest inverse association (11% decrease) observed for 4 servings of coffee a day. According to a scientifi c statement of the American Heart Association, coffee consumption is a minor clinical risk factor for heart failure [Schocken et al., 2008] .
Similar conclusions concern a potential correlation between coffee and stroke. Meta-analysis of the prospective studies, as well as epidemiologic studies published in 2011 and 2012, found that coffee consumption was not associated with a higher risk of stroke and that habitual moderate coffee consumption may even have a protective effect on stroke [Larsson & Orsini, 2011; Kim et al., 2012] .
Some authors also examined the impact of coffee drinking on the risk of atherosclerosis. One study has shown an inverse association [van Woudenbergh et al., 2008] , whereas the second study provided no evidence that coffee has either benefi cial or harmful impact on coronary and carotid atherosclerosis [Reis et al., 2010] .
Studies on the association between coffee consumption and mortality in patients with CVD have generated confl icting results. Some researchers found that heavy coffee consumption was signifi cantly related to a higher risk of sudden cardiac death, but other studies found no association or lower risk of CVD events . A cohort study conducted by Bidel et al. [2006] revealed that drinking >2 cups of coffee per day is associated with reduced CVD mortality among patients with type 2 diabetes mellitus.
Mixed results of the above mentioned studies may be conditioned by inadequate adjustment for many confounding factors, such as smoking, diet, variation in cup sizes and brewing methods [Silletta & Marchioli, 2008] .
IMPACT OF COFFEE ON BLOOD LIPIDS AND HOMOCYSTEINE CONCENTRATIONS
Coffee is a complex mixture of many biologically active substances that may have either benefi cial or harmful impact on health [Silletta & Marchioli, 2008] . To a large extent, the components found in coffee depend on the brewing method. Unfi ltered coffee is rich in cholesterol-raising diterpenes, including cafestol and kahweol The literature indicates a strong relationship between unfi ltered coffee consumption and elevated cholesterol and triglyceride levels, whereas paper-fi ltered coffee has been less frequently reported to raise the levels of these lipids [Dworzański et al., 2011; Ranheim & Halvorsen, 2005] . A positive association between unfi ltered coffee drinking and plasma cholesterol concentration has been revealed, especially by a study from Scandinavia, where coffee grounds are traditionally boiled without fi ltering [Weusten-Van der Wouw et al., 1994; Urgert & Katan, 1996] . Studies form the United States and the United Kingdom, where fi ltered coffee is extremely popular, did not report a signifi cant association [Riksen et al., 2009] . In contrast, Corrêa et al. [2013] , in a randomized clinical trial found that drinking 3-4 cups of paper-fi ltered coffee per day for 4 weeks increased total cholesterol concentration and low-density lipoprotein-cholesterol by 10-12% and 12-14%, respectively.
The conclusions of meta-analyses from 2001 and 2012, that consumption of unfi ltered coffee increases serum lipids levels, have not changed despite over a 10-year period between the two papers [Cai et al., 2012; Jee et al., 2001 ]. In the fi rst meta-analysis, Jee et al. [2001] concluded that consumption of 6 cups of coffee per day was signifi cantly associated with a mean increase in total cholesterol (11.8 mg/dL), LDL cholesterol (6.5 mg/dL), and triglyceride (5.9 mg/dL) level, but not with HDL cholesterol level. Filtered coffee resulted in very little change in serum cholesterol [Jee et al., 2001] . Both meta-analyses revealed that patients with hyperlipidemia were more sensitive to the lipid-raising effect of coffee.
Also, coffee consumption has been adversely associated with plasma homocysteine concentration [Higdon & Frei, 2006; van Dam, 2008; Verhoef & Groot, 2005] . Hyperhomocysteinaemia is considered to be a risk factor for the development of cardiovascular diseases [van Oijen et al., 2007] . A randomized study performed in the Netherlands suggested that drinking 1 L of unfi ltered coffee per day for two weeks increases mean plasma homocysteine by 10% [Grubben et al., 2000] . However, a study in the Norwegian population showed a strong dose-response relationship between coffee intake and total homocysteine levels, irrespective of the type of coffee (fi ltered, boiled, instant). Heavy coffee consumption (9 cups/day) was associated with a mean increase in homocysteine concentration by 18% and 29% for men and women, respectively [Nygard et al., 1997] . Plasma homocysteine concentration may also depend on the dietary intake of methionine, vitamins B-12 and B-6, and folic acid. However, in both of the above mentioned reports concentrations of homocysteine appear to have been independent of the intake of these compounds.
In contrast, other studies showed no changes in the concentration of homocysteine after consumption of 3-4 cups of paper-fi ltered coffee per day [Corrêa et al., 2013] . Also, abstention from fi ltered coffee for six weeks was demonstrated to be associated with a 10%-decrease in homocysteine concentration in consumers of approximately 4 cups of coffee per day [Christensen et al., 2001 ].
In conclusion, some authors are of the opinion that patients with dyslipidemia should be advised to drink fi ltered rather than non-fi ltered coffee . However, these authors noticed that, due to low-quality evidence, no general recommendations can be issued with regard to blood pressure and hypertension versus coffee consumption.
As far as patients with hypertension are concerned, a recently published systematic review and meta-analysis of controlled trials failed to deliver evidence justifying avoidance of habitual coffee consumption in well-controlled hypertensive patients [Mesas et al., 2011] .
In conclusion, according to the Guidelines for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology, a fi rm recommendation for or against coffee consumption cannot to be issued due to insuffi cient quality of most studies [Mancia et al., 2013] . In the United States restricted coffee consumption is no longer advised according to the recent Evidence-Based Guideline for the Management of High Blood Pressure in Adults [James et al., 2014] .
BENEFICIAL COMPOUNDS OF COFFEE AND THEIR SUGGESTED ACTION IN THE BODY
Coffee contains potentially benefi cial and harmful ingredients, which may interact in their physiological effects. Apart from caffeine and diterpenes, coffee contains polyphenols (which act as antioxidants), potassium, magnesium, and niacin. These constituents can be responsible for the suggestive benefi cial effects of coffee and they can balance the negative action of other ingredients [Bøhn et al., 2012] . In some populations coffee contributes to a large share of the consumption of polyphenols. In Finland, Spain, and Norway coffee is their primary source, whereas in Poland and Japan coffee is one of the most important sources of these compounds [Zujko et al., 2015; Fukushima et al., 2009] .
Composition of coffee is determined by strength of the brew and brewing methods. Stronger brews may have higher levels of caffeine, antioxidants and other compounds [Mostofsky et al., 2012] . Caffeine concentration per cup ranges from 28 to 322 mg, depending on the type of coffee and volume of serving [Crozier et al., 2012; Jarosz et al., 2012; O'Keefe et al., 2013] . According to the Polish nutrient databases, a cup of coffee (160 mL) provides 201 mg of potassium, 19 mg of magnesium, and 1.1 mg of niacin, which could amount to 4%, 5%, and 7% of the recommended dietary allowance for these nutrients, respectively [Kunachowicz et al., 2005] .
It remains unclear which compounds are responsible for the potential health-promoting properties of coffee, but they are mainly attributed to polyphenols [Bøhn et al., 2012; Butt & Sultan, 2011] . Chlorogenic acid is one of the major and well-known polyphenols of coffee [Higdon & Frei, 2006 ; O' Keefe et al., 2013] . A single serving of coffee provides between 20 and 675 mg of this compound [Cano-Marquina et al., 2013] . The mechanism of benefi cial effects of chlorogenic acid on the cardiovascular system is mainly associated with improved antioxidant status of the body, which protects it from the hazardous effect of free radicals and prevents endothelial damage [Butt & Sultan, 2011; Zujko et al., 2015] . As far as antioxidant potency of caffeine is concerned, some studies have suggested both strong antioxidant ability of caffeine [Devasagayam et al., 1996] , and weak anti-radical activity of this substance [Zhao et al., 2015] . However the study by Buscemi et al. has shown that caffeinated coffee had only 15% higher anti-oxidant capacity than decaffeinated coffee [Buscemi et al., 2010] .
Consumption of coffee appears to have favourable effects on some markers of subclinical infl ammation. One study found that drinking 8 cups of coffee per day decreased the concentrations of proinfl ammatory interleukin-18 [Kempf et al., 2010] , whereas another reported an inverse correlation between the consumption of 1 cups of coffee per day and the level of C-reactive protein [Kotani et al., 2008] .
CONFOUNDING FACTORS OF THE HEALTH EFFECTS OF COFFEE
It is important to stress that lifestyle-related factors may modify the infl uence of coffee on health. Heavy coffee consumption tends to be strongly associated with cigarette smoking and with other unhealthy behaviours [Floegel et al., 2012; Higdon & Frei, 2006; Lopez-Garcia et al., 2006] . The Hordaland Homocysteine Study in Norway showed that combination of cigarette smoking and high coffee intake was associated with particularly high homocysteine concentration [Nygard et al., 1997] . Another study also found that smoking combined with high coffee consumption has a particularly unfavourable effect on acute myocardial infraction [D' Avanzo et al., 1993] . Nevertheless, the literature reports suggest that increased rates of coronary heart diseases in smokers who drink much coffee occur as a result of cigarette smoking, not coffee consumption [Harland, 2000] . A study by Lopez--Garcia et al. [2006] revealed that detrimental effects of smoking on coronary heart diseases were the same among coffee drinkers and non-drinkers.
Interindividual differences in relation between coffee and health might also be conditioned by genetic factors [Cano-Marquina et al., 2013; Dworzański et al., 2011] . There is substantial evidence that the CYP1A2 genotype of cytochrome P450, which accounts for 95% of the primary metabolism of caffeine, modifi es the association between coffee consumption and cardiovascular risk [Dworzański et al., 2011; Mostofsky et al., 2012] . Some study revealed that an intake of 4 cups of coffee per day may increase the risk of non-fatal myocardial infarction only among individuals with the variant CYP1A2*1F allele who are 'slow' caffeine metabolizers, but not among CYP1A2*1A allele carriers who are 'rapid' caffeine metabolizers [Cornelis et al., 2006] .
CONCLUSIONS
Recent research has indicated that habitual moderate coffee intake does not pose a health threat and may even be associated with benefi cial effects on the cardiovascular health. According to some experts, coffee can become a part of a healthy diet for the general public and also for those with cardiovascular risk or cardiovascular diseases Recommendation to reduce coffee consumption as means of lowering the risk of coronary heart disease is not required [van Dam, 2008] . However, it is important to note that strong brews of coffee contain a lot of caffeine, which is a psychoactive substance. Caffeine is also present in other popular products in the diet, i.e. tea, cola drinks, chocolate, and energy drinks. High intake of caffeine may cause a wide range of adverse effects, including psychomotor agitation, insomnia, gastrointestinal complaints and tachycardia. Therefore, one should exercise caution when encouraging high consumption of coffee as a preventive measure for cardiovascular diseases.
